Medicament for treating cancer

Details Medicament for treating cancer Medicament for treating cancer

2011-02-01

2011-02-01

Harris, Alana M. (Department: 1643)

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

Monoclonal antibody or fragment thereof

C424S130100, C424S133100, C424S138100, C424S141100, C424S142100, C424S155100, C424S156100, C424S172100, C424S174100

Reexamination Certificate

active

07879327

ABSTRACT:
A medicament for treating cancer for use in combination therapy with an anti-HER2 antibody, which comprises amrubicin or a pharmaceutically acceptable salt thereof as an active ingredient.

REFERENCES:
patent: 5677171 (1997-10-01), Hudziak et al.
patent: 6156321 (2000-12-01), Thorpe et al.
patent: 2003/0068318 (2003-04-01), O'Brien et al.
patent: 03-005397 (1991-01-01), None
Baselga, J. et al. Journal of Clinical Oncology, 14(3): 737-744, 1996.
Baselga, J. et al. Cancer Research, 58:2823-2831, Jul. 1998.
Agus et al. Seminars in Oncology), vol. 27, No. 6, pp. 53-63 (2000).
Baselega et al. Cancer Research Vo. 58, pp. 2825-2831 (1998).
Graus-Porta et al. EMBO J., vol. 16 pp. 1647-1655 (1997).
Glisson et al. Clinical Cancer Research, vol. 20 pp. 944-946, (2004).
Hida et al. Clinical Cancer Research, pp. 2006-2011, (2000).
Johns Hopkins Pathology Website—(http://ovariancancerjhmi.edu/recurrentqa.cfm), May 2, 2006.
Karunagaran et al. EMBO J., vol. 15, pp. 254-264, (1996).
Kern et al. Cancer Research, vol. 16, pp. 5184-5187, pp. 88-91, (1990).
Kim et al. Lung Cancer, vol. 22, pp. 181-190, (1998).
Lewis et al. Cancer Immunology Immunotherapy, vol. 37, pp. 255-263, (1993).
Noonberg et al. Drugs, vol. 59, No. 4, pp. 753-767, (2000).
Ogawa, M. J. Cancer Res. Clin. Oncol., vol. 125, pp. 134-140, (1999).
Pergram M. et al. Oncogene, vol. 18, No. 13, pp. 2241-2251, Apr. 1999.
Pergram et al. J. Clin. Oncol., vol. 16, pp. 2659-2671, (1998).
Perry, C.M. et al. BioDrugs, vol. 12, No. 2, pp. 129-135, Aug. 1999.
Roitt et al. Immunology, Mosby St Louis, pp. 6.4-66.5, (1993).
Stancovski, et al. PNAS, USA, vol. 88, pp. 8691-8685, (1991).
Strobel et al. Gynecologic Oncology, vol. 73, pp. 362-367, (1999).
Winter et al. TIPS, vol. 14, pp. 139-143, (1993).
Morisada, S., et al., “Antitumor Activities of a Novel 9-Aminoanthracycline (SM-5887) against Mouse Experimental Tumors and Human Tumor Xenografts,” Jpn. J. Cancer Res., vol. 80, pp. 69-76 (1989).
Canadian Patent Office Office Action issued May 28, 2010 for corresponding Application No. 2,417,255.

Affiliated with

Also associated with

Rating

Medicament for treating cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Medicament for treating cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicament for treating cancer will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2621735